papillary thyroid cancer glp 1 GLP-1 receptors (GLP-1R) are expressed in premalignant lesions in human GLP-1 medications and thyroid cancer
Description
Retatrutide, an experimental weight-loss drug, has not been approved by the FDA
Wei P, Yang Y, Li T, Ding Q, Sun H
%20-%202026-02-12T083130.527.jpg?w=1200&max-h=1200&fit=crop&auto=format)
Just know this has not yet been evaluated in clinical trials
Sustainable results depend more on a comprehensive, individualized care plannot medication alone.
